<DOC>
	<DOC>NCT00398619</DOC>
	<brief_summary>The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.</brief_summary>
	<brief_title>A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes</brief_title>
	<detailed_description>"Proprietary Information: Exploratory (Non-Confirmatory) Trial".</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Male and female subjects between 18 years and 65 years of age. BMI between 30 and 42 kg/m2, inclusive. FPG &lt;126 mg/dL Meet criteria for diagnosis of diabetes mellitus at the screening evaluation, female subjects with a history of gestational diabetes are permitted. Are receiving oral antidiabetic agents within the 3 months prior to screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>